SCHEMBL455700

SCHEMBL455700

O=C1C(=NNC(=S)Nc2ccc([N+](=O)[O-])cc2)Nc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
MAPT P10636 8/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
LMNA P02545 5/20 0.47
HTT P42858 5/20 0.47
GAA P10253 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
ALOX12 P18054 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
NPC1 O15118 1/20 0.47
RRM1 P23921 1/20 0.45
RRM2 P31350 1/20 0.45
RRM2B Q7LG56 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
TTR P02766 1/20 0.43
LRRK2 Q5S007 1/20 0.43
HPGD P15428 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL457126 0.87 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL455908 0.85 RRM1 (0.44) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL469874 0.84 TTR (0.57) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL2877863 0.84 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL2877739 0.84 MAPT (0.51) ALDH1A1MAPTSMN1; SMN2LMNAGAA
SCHEMBL456579 0.82 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL455312 0.81 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL455238 0.81 RAB9A (0.44) ALDH1A1MAPTSMN1; SMN2LMNAGAA
SCHEMBL457421 0.81 LRRK2 (0.42) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL456909 0.81 BCHE (0.43) ALDH1A1MAPTSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed